| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Neurosurgery [J. S. R., S. M., R. S.] and Neuro-Oncology [P. A. S.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892 [W. G. S. S., L. A. L.]
Local invasive growth is one of the key features of primary malignant brain tumors accompanied by remodeling of the vasculature and destruction of normal brain tissue. Tissue invasiveness is an essential biological function used by a tumor to overcome the various barriers to its progression. The expression of metalloproteases has been shown to play a critical role in the invasive process in a number of tumors; however, their expression in human brain tumors has not been previously reported. In this study we showed metalloprotease activities at Mr 240,000, 123,000, 92,000, 72,000, and 67,000 in brain tumor extracts. These enzyme activities were inhibited by EDTA, an inhibitor of metalloproteases. Significant increases in levels of protease bands at Mr 92,000, 123,000, and 240,000 were observed in glioblastoma and metastatic lung tumors. Enzymatic inhibition and Western blotting with Mr 92,000 type IV collagenase antibody confirmed the presence of Mr 92,000 type IV collagenase in all samples. Quantitative analysis by densitometry showed 8–10-fold and 6–8-fold increases in Mr 92,000 type IV collagenase activity in glioblastoma and metastatic lung carcinoma samples, respectively, when compared with normal brain, meningioma, astrocytoma, metastatic colon, and breast carcinoma samples. These findings provide evidence for elevated levels of metalloproteases in glioblastomas and suggest a therapeutic target for minimizing the invasive propensity of gliomas using protease inhibitors.
1 Support for these studies was provided in part by the Tunica Foundation, the Windey Will Case Foundation (Chicago), and IRG and PRS funds were provided by the University of Texas M. D. Anderson Cancer Center, Houston, Texas.
2 To whom requests for reprints should be addressed, at Department of Neurosurgery, Box 064, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.
Received 2/15/93. Accepted 4/ 1/93.
This article has been cited by other articles:
|
|
 |
|
  M. T. Mandara, S. Pavone, L. Mandrioli, G. Bettini, C. Falzone, and M. Baroni Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Expression in Canine and Feline Meningioma Vet. Pathol., September 1, 2009; 46(5): 836 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-S. Kim, H.-J. Kwak, J.-W. Lee, H.-J. Kim, M.-J. Park, J.-B. Park, K.-H. Choi, H. Yoo, S.-H. Shin, W.-S. Shin, et al. 17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion Mol. Cancer Res., November 1, 2008; 6(11): 1657 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Tippett, L. K. Dodgson, N. P. Hunt, and M. P. Lewis Indices of extracellular matrix turnover in human masseter muscles as markers of craniofacial form--a preliminary study Eur J Orthod, April 1, 2008; 30(2): 217 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.R.M. Ruhul Amin, M. H. Uddin Biswas, T. Senga, G.-S. Feng, R. Kannagi, M. L. Agarwal, and M. Hamaguchi A role for SHPS-1/SIRP{alpha} in Concanavalin A-dependent production of MMP-9 Genes Cells, September 1, 2007; 12(9): 1023 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grommes, G. E. Landreth, M. Sastre, M. Beck, D. L. Feinstein, A. H. Jacobs, U. Schlegel, and M. T. Heneka Inhibition of in Vivo Glioma Growth and Invasion by Peroxisome Proliferator-Activated Receptor {gamma} Agonist Treatment Mol. Pharmacol., November 1, 2006; 70(5): 1524 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Moshal, U. Sen, N. Tyagi, B. Henderson, M. Steed, A. V. Ovechkin, and S. C. Tyagi Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway Am J Physiol Cell Physiol, March 1, 2006; 290(3): C883 - C891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas J. Biol. Chem., June 10, 2005; 280(23): 21882 - 21892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Freije, F. E. Castro-Vargas, Z. Fang, S. Horvath, T. Cloughesy, L. M. Liau, P. S. Mischel, and S. F. Nelson Gene Expression Profiling of Gliomas Strongly Predicts Survival Cancer Res., September 15, 2004; 64(18): 6503 - 6510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Lakka, C. S. Gondi, N. Yanamandra, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao Synergistic Down-Regulation of Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase-9 in SNB19 Glioblastoma Cells Efficiently Inhibits Glioma Cell Invasion, Angiogenesis, and Tumor Growth Cancer Res., May 15, 2003; 63(10): 2454 - 2461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shiraga, S. Yano, A. Yamamoto, H. Ogawa, H. Goto, T. Miki, K. Miki, H. Zhang, and S. Sone Organ Heterogeneity of Host-derived Matrix Metalloproteinase Expression and Its Involvement in Multiple-Organ Metastasis by Lung Cancer Cell Lines Cancer Res., October 15, 2002; 62(20): 5967 - 5973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Esteve, E. Chicoine, O. Robledo, F. Aoudjit, A. Descoteaux, E. F. Potworowski, and Y. St-Pierre Protein Kinase C-zeta Regulates Transcription of the Matrix Metalloproteinase-9 Gene Induced by IL-1 and TNF-alpha in Glioma Cells via NF-kappa B J. Biol. Chem., September 13, 2002; 277(38): 35150 - 35155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller, S. Mohanam, and J. S. Rao Expression of Tissue Factor Pathway Inhibitor 2 Inversely Correlates during the Progression of Human Gliomas Clin. Cancer Res., March 1, 2001; 7(3): 570 - 576. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bhattacharya, S. S. Lakka, S. Mohanam, D. Boyd, and J. S. Rao Regulation of the Urokinase-type Plasminogen Activator Receptor Gene in Different Grades of Human Glioma Cell Lines Clin. Cancer Res., February 1, 2001; 7(2): 267 - 276. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kondraganti, S. Mohanam, S. K. Chintala, Y. Kin, S. L. Jasti, C. Nirmala, S. S. Lakka, Y. Adachi, A. P. Kyritsis, F. Ali-Osman, et al. Selective Suppression of Matrix Metalloproteinase-9 in Human Glioblastoma Cells by Antisense Gene Transfer Impairs Glioblastoma Cell Invasion Cancer Res., December 1, 2000; 60(24): 6851 - 6855. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. A. Raithatha, H. Muzik, N. B. Rewcastle, R. N. Johnston, D. R. Edwards, and P. A. Forsyth Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas Neuro-oncol, July 1, 2000; 2(3): 145 - 150. [Abstract] [PDF]
|
|
|
|
 |
|
 U. Mahmood, C.-H. Tung, A. Bogdanov Jr, and R. Weissleder Near-Infrared Optical Imaging of Protease Activity for Tumor Detection Radiology, December 1, 1999; 213(3): 866 - 870. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z.-S. Zeng, A. M. Cohen, and J. G. Guillem Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis Carcinogenesis, May 1, 1999; 20(5): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Levin Neuro-oncology: An Overview Arch Neurol, April 1, 1999; 56(4): 401 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Price, Q. Shi, D. Morris, M. E. Wilcox, P. M. A. Brasher, N. B. Rewcastle, D. Shalinsky, H. Zou, K. Appelt, R. N. Johnston, et al. Marked Inhibition of Tumor Growth in a Malignant Glioma Tumor Model by a Novel Synthetic Matrix MetalloproteinaseInhibitor AG3340 Clin. Cancer Res., April 1, 1999; 5(4): 845 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maekawa, H. Maki, H. Yoshida, K. Hojo, H. Tanaka, T. Wada, N. Uchida, Y. Takeda, H. Kasai, H. Okamoto, et al. Correlation of Antiangiogenic and Antitumor Efficacy of N-biphenyl Sulfonyl-phenylalanine Hydroxiamic Acid (BPHA), an Orally-active, Selective Matrix Metalloproteinase Inhibitor Cancer Res., March 1, 1999; 59(6): 1231 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iizasa, T. Fujisawa, M. Suzuki, S.-i. Motohashi, K. Yasufuku, T. Yasukawa, M. Baba, and M. Shiba Elevated Levels of Circulating Plasma Matrix Metalloproteinase 9 in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., January 1, 1999; 5(1): 149 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qin, J. D. Moellinger, A. Wells, L. J. Windsor, Y. Sun, and E. N. Benveniste Transcriptional Suppression of Matrix Metalloproteinase-2 Gene Expression in Human Astroglioma Cells by TNF-{alpha} and IFN-{gamma} J. Immunol., December 15, 1998; 161(12): 6664 - 6673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lampert, U. Machein, M. R. Machein, W. Conca, H. H. Peter, and B. Volk Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors Am. J. Pathol., August 1, 1998; 153(2): 429 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Chintala, R. Sawaya, B. B. Aggarwal, S. Majumder, D. K. Giri, A. P. Kyritsis, Z. L. Gokaslan, and J. S. Rao Induction of Matrix Metalloproteinase-9 Requires a Polymerized Actin Cytoskeleton in Human Malignant Glioma Cells J. Biol. Chem., May 29, 1998; 273(22): 13545 - 13551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kleifeld, P. E. Van den Steen, A. Frenkel, F. Cheng, H. L. Jiang, G. Opdenakker, and I. Sagi Structural Characterization of the Catalytic Active Site in the Latent and Active Natural Gelatinase B from Human Neutrophils J. Biol. Chem., October 27, 2000; 275(44): 34335 - 34343. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
